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Abstract
Background: Ecthyma gangrenosum (EG) manifests as a skin lesion affecting patients suffering extreme
neutropenia and is commonly associated with Pseudomonas aeruginosa in immunocompromised patients.
Leukocyte adhesion deficiency I (LAD I) which count among primary immunodeficiency syndromes of the innate
immunity, is an autosomal recessive disorder characterized in its severe phenotype by a complete defect in CD18
expression on neutrophils, delayed cord separation, chronic skin ulcers mainly due to recurrent bacterial and fungal
infections, leucocytosis with high numbers of circulating neutrophils and an accumulation of abnormally low
number of neutrophils at sites of infection.
Case Presentation: We report at our knowledge the first case of a child affected by LAD-1, who experienced
during her disease course a multi-bacterial and fungal EG lesion caused by fusarium solani. Despite targeted
antibiotics and anti-fungi therapy, the lesion extended for as long as 18 months and only massive granulocytes
pockets transfusions in association with G-CSF had the capacity to cure this lesion.
Conclusion: We propose that granulocytes pockets transfusions will be beneficial to heal EG especially in severely
immunocompromised patients.
Background
Leukocyte adhesion deficiency I (LAD I) is an autosomal
recessive disorder characterized by defect in CD18 expres-
sion on neutrophils, leading to leucocytosis with high
numbers of circulating neutrophils and an accumulation
of abnormally low number of neutrophils at sites of infec-
tion. Recurrent bacterial and fungal infections count
among clinical complications of such disorder [1]. None-
theless, ecthyma gangrenosum (EG) which represents a
cutaneous infection mainly associated with pseudomonal
sepsis in immunocompromised patient suffering
extreme neutropenia [2,3], was never reported in the set-
ting of LAD I.
We report a case of a child affected by LAD-1, who
experienced a fusarium solani EG lesion. The lesion
e x t e n d e df o ra sl o n ga s1 8m o n t h sa n do n l ym a s s i v e
granulocytes pockets transfusions in association with
G-CSF had the capacity to cure this lesion.
Case presentation
A 9 years old girl affected by LAD-1 developed after a
fall an abscess on her knee. Cultures taken from the
lesion revealed a Pseudomonas aeruginosa infection. She
was treated with amikacine 400 mg/day and imipenem
400 × 2 mg/day for three weeks and local disinfection.
Lesion cultures performed one month later were nega-
tive. As all patients affected by such immunodeficiency,
she was constantly under prophylactic treatment
[25 mg/Kg/2 days (sulfamethoxazole + trimetoprime)
and 10 mg/Kg/day Itraconazole].
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cm diameter erythematous and edematous lesion around
necrotic center consistent with EG. The patient was
apyretic and no pus was present. Laboratory findings
were: peripheral WBC 23,000 mm3 (86% neutrophils);
hemoglobin 8 g/dL. C-reactive protein was 106 mg/dL.
Skin biopsies showed epidermal necrosis and ulceration
with inflammatory granular cell infiltrates composed
largely by lymphocytes, plasma cells, histiocytes, macro-
phages and rare eosinophiles. At that time, a necrotic
vasculitis was confirmed but no bone lesion was found.
During 11 months and despite targeted antibiotic and
anti-fungal therapy, cultures taken both from the lesion
and from the blood were positive for several bacteria
(especially Pseudomonas aeruginosa) and a persistent
fusarium solani. While a Broviack central catheter for
amphotericine B administration was installed, cultures
remained positive and the lesion enlarged with none
improvement (Figure 1). X-ray radiography showed
bone lesions and signs of demineralization on the upper
extremity of the shinbone. Bone scan revealed a perios-
teal reaction and magnetic resonance imagery a medul-
lar edema.
In front of this over a year persistent infection, we
started transfusions of irradiated, phenotyped granulo-
cytes pockets (3 pockets per week in median) along with
G-CSF 5 μg/Kg/day; liposomal amphotericine B (Abelcet
2 mg/Kg/day), amphotericine B (0,3 mg/Kg/day up to 2
mg/Kg/day), flucytosine, and targeted antibiotics.
Amphotericine B was stopped after 6 months and only
granulocytes transfusions, G-CSF and Flucytosine were
administered for the 2 latter months (Figure 1). After
almost 5 months of such treatment cultures became
negative, EG reduced progressively and then disappeared
completely. Healing was complete but poorly formed as
for patients suffering of such primary immunodeficiency.
Discussion
EG is one of the most serious cutaneous infections
which occurs frequently in patients with neutropenia
and underlying malignancies [4,5]. According to its
pathogenesis, there are two main types of EG, with and
without bacteremia. Skin lesions of the bacteremic type
occur by hematological spread and blood cultures are
positive, whereas in the better prognosis nonbacteremic
form, lesions occur on the skin where organisms are
inoculated [6]. Even though most lesions are located in
the gluteal and perineal regions [7], our patient had a
knee lesion following a trauma. After a restricted skin
location during months, there was a germs blood spread
and bacteremia episodes that may be responsible of EG
persistence in our patient. Moreover, lack of neutrophils
migration to infectious sites because of LAD constitutes
somewhat a delay of treatment and may explain second-
ary bacteremia as reported [8].
Pseudomonas aeruginosa was the first bacteria isolated
and was almost always present [9] with fusarium solani in
our patients’ lesion (Figure 1). Less commonly, non-
pseudomonal pathogens like Citrobacter freundii, E. coli,
Aeromonas hydrophila, Stenotrophomonas maltophilia,
Staphylococcus aureus, and non-bacteremic states have
been associated with EG [2]. Only one case of fusarium
solani EG about a child affected by acute leukemia relapse
was published [10]. Evolution was favorable and the child
was completely cured when he recovered from aplasia.
The fundamental difference between our case and those
reported is the permanent condition of granulocyte ineffi-
ciency for our patient. Whereas for patients not affected
by LAD I, treatment result can’t be completely dissociated
of granulocyte recovery. While neutropenia represent [2,3]
the major predisposing factor for EG, the failure of neuto-
phils to reach lesion location due to adhesion molecule
deficiency in our patient, confirms the prominent role of
these cells in curing such lesion. The therapeutic strategy
of giving G-CSF beside transfusions was used to extend
granulocytes half life. G-CSF was yet used in a child with
acute lymphoblastic leukemia suffering from disseminated
hyalohyphomycosis due to fusarium solani who developed
an ecthyma gangrenosum-like lesion [11]. This particular
therapy supplies fresh normal granulocytes able to supple-
ment drug effects. As granulogytes deficiency and/or inef-
ficiency constitutes the primum movens of EG occurrence,
granulocytes transfusions along with targeted drug therapy
seems to be the best supportive mean to cure EG lesions,
especially in severely immunocompromised patients.
For our patient, EG lesion was a result of a relatively
unusual germ (fusarium solani) and extended over one
year despite aggressive and specific therapy. Bacterial
Figure 1 Evolution of isolated bacteria in EG and blood
cultures. Along with bacteria identification, a targeted antibiotic
therapy was administrated. G-CSF: Granulocytes-colony stimulating
factor.
a: blood culture;
b: blood and EG culture. 1- Pseudomonas
aeruginosa; 2- Enterobactium cloacae; 3- Enterobacterium faecalis;
4- Fusarium solani; 5- E. coli; 6- Streptococus epidermidis;
7- Staphylococus haemolyticus; 8- Staphylococus epidermidis
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ing element either by itself or by the massive antibiotic
therapy used. Both intensive monitoring and targeted
therapy probably with the overriding granulocytes trans-
fusion role permitted EG healing.
An oral informed consent was obtained from the
father of the patient for publication of this case report.
Conclusion
EG is a rare dermatologic infection due generally to bac-
teria and is commonly observed in patients with malig-
nancy or neutropenia. Occurrence of such lesion
secondary to fusarium solani in LAD I affected patient
represents to our knowledge the first reported case.
Granulocytes transfusions seem to be a good therapeutic
option in such patient. This therapy can be generalized
in severely immunocompromised patients affected by
EG and/or in worst prognosis EG septicemic forms.
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